title: Biphasic regulation of mammary epithelial resistance by serotonin through activation of multiple pathways.
abstract: Mammary gland homeostasis and the lactation-to-involution switch are regulated by serotonin (5-hydroxytryptamine (5-HT)). Mammary epithelial tight junctions are physiological targets of 5-HT, and their disruption marks an early stage of mammary gland involution. In these studies, we have identified signal transduction mechanism employed by 5-HT during regulation of mammary gland transepithelial resistance. Transepithelial electrical resistance and tight junction protein architecture were studied in cultures of MCF10A human mammary epithelial cells. Serotonin had biphasic effects on mammary epithelial resistance. At lower concentrations and earlier time points, 5-HT potentiated epithelial transmembrane resistance, whereas at higher concentrations and later time points, 5-HT decreased transepithelial electrical resistance and disrupted tight junctions. Both the early and delayed actions of 5-HT were mediated by the 5-HT7 receptor through activation of G(s)/cAMP. 5-HT induced the activities of both protein kinase A and p38 mitogen-activated protein kinase. Inhibition of p38 mitogen-activated protein kinase abrogated 5-HT-induced disruption of mammary epithelial tight junctions (the delayed effect). In contrast, inhibition of protein kinase A prevented the increased epithelial resistance in response to 5-HT (the transient effect). These studies imply an integrated set of mechanisms whereby transient, modest activation of 5-HT7 promotes tight junction integrity, and sustained 5-HT7 activation drives involution by disrupting tight junctions.
authors.affiliation: Department of Molecular and Cellular Physiology, University of Cincinnati, Cincinnati, Ohio 45267-0576, USA.
authors.forename: Vaibhav P
authors.initials: VP
authors.lastname: Pai
authors.forename: Nelson D
authors.initials: ND
authors.lastname: Horseman
mesh_terms: D045744:Cell Line, Tumor; D017868:Cyclic AMP-Dependent Protein Kinases / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D017097:Electric Impedance; D005260:Female; D006801:Humans; D020935:MAP Kinase Signaling System / Q000187:drug effects* / Q000502:physiology; D042361:Mammary Glands, Human / Q000166:cytology / Q000378:metabolism*; D011985:Receptors, Serotonin / Q000378:metabolism*; D012701:Serotonin / Q000494:pharmacology*; D019108:Tight Junctions / Q000378:metabolism*; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism*
chemical_list: D011985:Receptors, Serotonin; C104425:serotonin 7 receptor; D012701:Serotonin; D017868:Cyclic AMP-Dependent Protein Kinases; D048051:p38 Mitogen-Activated Protein Kinases
references.citation: J Cell Biol. 2000 Nov 27;151(5):F31-6
references.pmid: 11086016
references.citation: J Cell Physiol. 2005 Jun;203(3):564-72
references.pmid: 15605377
references.citation: Acta Endocrinol (Copenh). 1960 Jan;33:73-80
references.pmid: 13835391
references.citation: Annu Rev Cell Dev Biol. 2006;22:207-35
references.pmid: 16771626
references.citation: Am J Physiol. 1995 Oct;269(4 Pt 2):R848-55
references.pmid: 7485602
references.citation: J Biol Chem. 2001 Oct 19;276(42):38480-6
references.pmid: 11502742
references.citation: J Biol Chem. 1994 Jun 10;269(23):16108-15
references.pmid: 8206910
references.citation: J Pharmacol Exp Ther. 2005 Jun;313(3):1003-10
references.pmid: 15716386
references.citation: J Biol Chem. 1994 Mar 18;269(11):7851-4
references.pmid: 8132501
references.citation: Cell Signal. 1996 Jun;8(4):235-45
references.pmid: 8842523
references.citation: J Biol Chem. 2004 Apr 23;279(17):17366-75
references.pmid: 14970210
references.citation: J Mammary Gland Biol Neoplasia. 1998 Jul;3(3):233-46
references.pmid: 10819511
references.citation: Mol Endocrinol. 2002 Dec;16(12):2675-91
references.pmid: 12456789
references.citation: J Endocrinol. 2001 Aug;170(2):347-56
references.pmid: 11479131
references.citation: J Cell Biol. 1997 Jun 16;137(6):1393-401
references.pmid: 9182670
references.citation: Br J Pharmacol. 2004 Oct;143(3):404-10
references.pmid: 15339860
references.citation: Biochim Biophys Acta. 2008 Mar;1778(3):601-13
references.pmid: 18339298
references.citation: Proc Soc Exp Biol Med. 1959 Aug-Sep;101:699-703
references.pmid: 13829719
references.citation: J Cell Sci. 1993 Oct;106 ( Pt 2):641-8
references.pmid: 8282768
references.citation: J Biol Chem. 2005 Jul 15;280(28):26233-40
references.pmid: 15905176
references.citation: Zentralbl Gynakol. 1972 Dec 9;94(49):1081-6
references.pmid: 4650317
references.citation: Br J Pharmacol. 2002 Mar;135(6):1563-71
references.pmid: 11906971
references.citation: Biochim Biophys Acta. 2008 Mar;1778(3):729-56
references.pmid: 17950242
references.citation: Cell. 2002 Oct 4;111(1):29-40
references.pmid: 12372298
references.citation: Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8547-51
references.pmid: 8397408
references.citation: Mol Cell Endocrinol. 1999 Oct 25;156(1-2):55-61
references.pmid: 10612423
references.citation: Am J Physiol. 1997 Jul;273(1 Pt 2):R379-86
references.pmid: 9249575
references.citation: J Mammary Gland Biol Neoplasia. 2007 Mar;12(1):25-35
references.pmid: 17431797
references.citation: Methods. 2003 Jul;30(3):256-68
references.pmid: 12798140
references.citation: Breast Cancer Res. 2006;8(2):203
references.pmid: 16677411
references.citation: J Dairy Res. 1982 Feb;49(1):1-11
references.pmid: 7076943
references.citation: J Dairy Sci. 2008 May;91(5):1834-44
references.pmid: 18420614
references.citation: Adv Drug Deliv Rev. 2003 Apr 29;55(5):629-41
references.pmid: 12706546
references.citation: Cancer Res. 1990 Sep 15;50(18):6075-86
references.pmid: 1975513
references.citation: J Mol Endocrinol. 1998 Oct;21(2):169-77
references.pmid: 9801460
references.citation: J Dairy Sci. 1994 Feb;77(2):426-32
references.pmid: 8182166
references.citation: J Neurochem. 2003 Dec;87(5):1076-85
references.pmid: 14622088
references.citation: Rev Reprod. 1998 May;3(2):104-12
references.pmid: 9685189
references.citation: J Biol Chem. 2002 Jul 5;277(27):24197-203
references.pmid: 11978790
references.citation: Endocrinology. 1969 Jul;85(1):155-60
references.pmid: 4306740
references.citation: Am J Physiol. 1984 Jul;247(1 Pt 1):C20-5
references.pmid: 6742181
references.citation: Development. 1996 Jan;122(1):181-93
references.pmid: 8565829
references.citation: Brain Res. 1998 Feb 16;784(1-2):57-62
references.pmid: 9518551
references.citation: Endocrinology. 1994 Sep;135(3):1119-24
references.pmid: 8070355
references.citation: J Neurosci. 2005 Aug 24;25(34):7821-30
references.pmid: 16120784
references.citation: Pharmacol Ther. 2001 Nov-Dec;92(2-3):179-212
references.pmid: 11916537
references.citation: Am J Physiol Cell Physiol. 2004 Jun;286(6):C1213-28
references.pmid: 15151915
references.citation: Eur J Cancer. 2004 Dec;40(18):2717-25
references.pmid: 15571953
references.citation: Biochem J. 1987 Feb 15;242(1):285-8
references.pmid: 3593242
references.citation: J Biol Chem. 1993 Nov 5;268(31):23422-6
references.pmid: 8226867
references.citation: Dev Cell. 2004 Feb;6(2):193-203
references.pmid: 14960274
references.citation: Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16708-13
references.pmid: 17940054
references.citation: J Physiol. 1980 Apr;301:415-28
references.pmid: 7411441
references.citation: Exp Cell Res. 2007 May 1;313(8):1533-47
references.pmid: 17374535